Related Experiment Videos
Immunogenicity trial of inactivated hepatitis A virus vaccine in human volunteers
Kusov YuYu1, L B Elbert, I V Nelga
1Institute of Poliomyelitis and Viral Encephalitides, Moscow State Medical Institute, USSR.
Vaccine
|August 1, 1991
Abstract:
An inactivated hepatitis A virus (HAV) vaccine was tested on a group of human adult volunteers. The vaccine was administered subcutaneously, and a control group received a placebo (aluminium hydroxide). The vaccine was found to be relatively well tolerated and non-reactogenic, and levels of anti-HAV were comparable to those in other studies.